Trump administration says it’s reviewing all 55 million US visa holders | Donald Trump News
US State Department said it was continuously vetting all visa holders for possible violations. The United States Department…
Trump administration is reviewing all 55 million foreigners with US visas for any violations
WASHINGTON (AP) — The Trump administration said Thursday that it is reviewing more than 55 million people who…
Zelensky’s impossible choice – spiked
It was on 24 February 2022 that Volodymyr Zelensky made what remains the most fateful decision of his…
Trump Civil Fraud Ruling Boosts President’s Net Worth By $500 Million
Topline President Donald Trump got a major boost to his net worth Thursday thanks to the New York…
Powell to deliver Jackson Hole speech Friday. What Wall Street expects
Federal Reserve Chair Jerome Powell is set to deliver what almost certainly will be his last keynote address…
Trump administration reviewing 55M people with US visas for violations
WASHINGTON (AP) — The State Department said Thursday that it’s reviewing the records of more than 55 million…
Powell’s speech to be closely watched by Wall Street and the White House
WASHINGTON (AP) — Just three weeks ago, Federal Reserve Chair Jerome Powell spoke to reporters after the central…
US and EU release a bare-bones account of their trade deal
BRUSSELS (AP) — American and European Union officials released a bare-bones account Thursday of their trade deal that…
Trump says he’ll patrol Washington, federal officers deploy checkpoints
WASHINGTON (AP) — President Donald Trump plans to join a Thursday evening patrol in the nation’s capital as…
New York appeals court tosses $515m civil fraud penalty against Trump | Donald Trump News
An appeals court in New York has thrown out a civil fraud penalty that would have cost United…
Gabbard slashing intelligence office workforce and cutting budget by over $700 million
WASHINGTON (AP) — The Office of the Director of National Intelligence will dramatically reduce its workforce and cut…
European pharma secured a U.S. tariff win. Investors remain wary
European pharmaceutical firms gained some much-desired clarity on Thursday, with news that U.S. tariffs will be capped at…